Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 25 with actor and science advocate Alan Alda discussing communicating science
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Multiple Sclerosis Society Education Conference
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
BRIEF: Teva files for Copaxone-Laquinimod patent
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Neuro-Immune Interactions at Barrier Surfaces.
Neurological involvement in Primary Sjögren Syndrome.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Laquinimod in Relapsing-Remitting Multiple Sclerosis

Pages